Melanoma prevention using topical PBISe

Melanoma prevention using topical PBISe

Item
http://www.wikidata.org/entity/Q36384802
Current and future trials of targeted therapies in cutaneous melanomaModular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.Identification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressureThe Akt signaling pathway: an emerging therapeutic target in malignant melanoma.Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma.Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy.Post SELECT: selenium on trial.Selenium-containing histone deacetylase inhibitors for melanoma management.A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.Synthesis and evaluation of selenium-containing indole chalcone and diarylketone derivatives as tubulin polymerization inhibition agents.
P2860

Melanoma prevention using topical PBISe

Item
http://www.wikidata.org/entity/Q36384802
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Melanoma prevention using topical PBISe
@ast
Melanoma prevention using topical PBISe
@en
type
label
Melanoma prevention using topical PBISe
@ast
Melanoma prevention using topical PBISe
@en
prefLabel
Melanoma prevention using topical PBISe
@ast
Melanoma prevention using topical PBISe
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Melanoma prevention using topical PBISe
@en
P2093
P2860
P304
P31
P356
10.1158/1940-6207.CAPR-10-0202
P433
P478
P577
P5875
P698
P932